The New York Racing Association, Inc. (NYRA) announced Friday that it is collaborating with Quest Diagnostics to provide COVID-19 testing this Saturday and Sunday at Belmont Park, where a limited number of spectators will return to the track for the first time since the beginning of the COVID-19 pandemic.
The Quest Diagnostics Mobile Testing Unit will offer COVID-19 antigen tests, which return a result within 30 minutes. On both Saturday and Sunday, tests will be offered to spectators for $30. The Quest Diagnostics Mobile Testing Unit will be located near the Orange Parking Lot.
“COVID-19 testing is a powerful tool for providing insights that can foster safer environments. We commend the New York Racing Association for implementing this innovative program, which will benefit New Yorkers while providing a model other states can emulate to re-ignite their local economies,” said Cathy Doherty, Senior Vice President and Group Executive, Clinical Franchise Solutions and Marketing, Quest Diagnostics.
In accordance with New York State requirements, spectators must purchase track admission in advance and adhere to strict health and safety protocols designed to mitigate the risk of COVID-19.
In order to enter Belmont Park, in accordance with New York State requirements, all ticketed spectators must submit proof of a completed vaccination or a negative COVID-19 test result.
Ticketed spectators may submit proof of a negative COVID-19 test result by presenting a physical copy of the test result or digitally through the New York State Excelsior Pass.
For comprehensive information on health and safety protocols in effect for the Belmont Park spring/summer meet, please visit: https://www.nyra.com/belmont/visit/plan-your-visit.